Dyne Therapeutics (DYN) Treasury Shares (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Treasury Shares data on file, last reported at $4.6 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 53.02% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 53.02% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, down 34.49% from the prior year.
• Treasury Shares for Q1 2026 stood at $4.6 million, up from $2.4 million in the prior quarter.
• Over the last five years, Treasury Shares for DYN reached as high as $4.6 million in Q1 2026 and fell as low as $937688.0 in Q3 2022.
• Historically, Treasury Shares has averaged $2.4 million across 5 years, with a median of $2.6 million in 2025.
• Across the five-year window, Treasury Shares jumped 109.69% in 2022 and tumbled 34.49% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.7 million in 2022, then soared by 101.88% to $3.4 million in 2023, then grew by 8.76% to $3.7 million in 2024, then tumbled by 34.49% to $2.4 million in 2025, then surged by 90.24% to $4.6 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $4.6 million in Q1 2026, $2.4 million in Q4 2025, and $2.6 million in Q3 2025.